Genetic toxicity of dopamine

Area of Science:

• Biochemistry
• Genetics
• Toxicology

Background:

• Dopamine is a crucial neurotransmitter involved in various physiological processes.
• Understanding the potential genotoxicity of dopamine is important for assessing its safety.

Purpose of the Study:

• To evaluate the genetic toxicity of dopamine using a comprehensive battery of in vitro and in vivo assays.
• To investigate the mechanisms underlying any observed genotoxic effects.

Main Methods:

• DNA single-strand break analysis in human fibroblasts.
• Salmonella/mammalian-microsome mutagenicity test.
• Sister-chromatid exchange analysis in human lymphocytes.
• Mouse-lymphoma forward mutation assay.
• Sex-linked recessive lethal test in Drosophila melanogaster.
• Micronucleus test in mice and rats.
• In vitro DNA nicking and binding assays.

Main Results:

• Dopamine induced DNA strand breaks in human fibroblasts at concentrations of 50-300 µg/ml.
• Dopamine showed a dose-dependent increase in mutations in the mouse-lymphoma forward mutation assay (94-750 µg/ml).
• DNA strand breaks were inhibited by superoxide dismutase or dithiothreitol, suggesting a role for reactive oxygen species.
• Dopamine caused DNA nicking and bound to DNA in vitro.
• All other tested systems (bacterial mutagenicity, SCE, Drosophila, micronucleus) showed no response.

Conclusions:

• Dopamine exhibits genotoxic activity in vitro, specifically inducing DNA strand breaks and mutations.
• The in vitro genotoxicity is likely mediated by dopamine oxidation and the generation of reactive oxygen species, semiquinones, and quinones.
• It is unlikely that these genotoxic mechanisms would operate in vivo, suggesting dopamine is not genotoxic in living organisms under normal conditions.